| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |